Contributions
1,630 recent contributions in Hansard
HANSARDNottingham Maternity and Neonatal ServicesI refer hon. Members to the oral statement I made in the House today, 24 June 2026, on the publication of the report from the independent maternity and neonatal review of…24 Jun 2026HANSARDNottingham Maternity and Neonatal ServicesMy hon. Friend speaks about his constituents whose experience might be relevant to some of the findings around mortuary services and their failings. I would be happy to ensure a…24 Jun 2026HANSARDNottingham Maternity and Neonatal ServicesI thank my hon. Friend for sharing with us his experience of brain injury in his own family, and for reminding us how some of the issues that we are discussing today touch the…24 Jun 2026HANSARDNottingham Maternity and Neonatal ServicesMy hon. Friend is right to emphasise quite how shocking it is that people in senior leadership positions refused to take part in Donna Ockenden’s review. I cannot understand how…24 Jun 2026HANSARDNottingham Maternity and Neonatal ServicesI thank my hon. Friend for his comments, and for telling us what happened to his constituent. He asked about some of the wider changes that we are making in the NHS modernisation…24 Jun 2026HANSARDNottingham Maternity and Neonatal ServicesMy hon. Friend is absolutely right to point to regulatory failure, which has been drawn out very strongly by Donna Ockenden’s report. For me, what is completely unacceptable is…24 Jun 2026HANSARDNottingham Maternity and Neonatal ServicesI thank the hon. Gentleman for drawing my attention to that report. We will certainly ensure that any reports containing relevant recommendations are considered as part of the…24 Jun 2026HANSARDNottingham Maternity and Neonatal ServicesI thank the right hon. Gentleman for his remarks. The story he told was of yet another horrific and harrowing experience that a family has gone through in this scandal. He asked…24 Jun 2026HANSARDNottingham Maternity and Neonatal ServicesMy hon. Friend raises the important issue of compelling witnesses to give evidence. Although many members of staff contributed towards Donna Ockenden’s review, I found the fact…24 Jun 2026HANSARD Puberty BlockersI will give way one more time, and then I will make some progress.23 Jun 2026HANSARD Puberty BlockersI have responsibility for NHS England as Secretary of State for Health and Social Care, and I am setting out the protocol agreed in relation to this trial, as it is a subject that…23 Jun 2026HANSARD Puberty BlockersI will make a little progress, and then I will be open to more interventions. We need to be clear about who we are talking about. As Dr Cass said, the vast majority of children…23 Jun 2026HANSARD Puberty BlockersI know what a sensitive, emotive and difficult issue this is. As I said in the House yesterday, I have myself struggled with the profound challenges this subject raises. We all,…23 Jun 2026HANSARD Puberty BlockersThe hon. Gentleman’s question allows me to address that matter directly. The data-linkage study will not provide clear evidence of the risks and benefits of puberty-suppressing…23 Jun 2026HANSARD Puberty BlockersThe hon. Gentleman raises an important question around how the clinical trial is designed. In this case, the young people involved in the trial, of whom there will be around 226,…23 Jun 2026HANSARD Puberty BlockersI thank the right hon. Gentleman for the tone he took in asking an important question, which I am pleased to be able to respond to. The bar for getting on to this trial is set…23 Jun 2026HANSARD Puberty BlockersThe MHRA has introduced additional safeguards. As a result of its dialogue with the trial sponsors, the amended protocol published last week increases the level of safeguards.…23 Jun 2026HANSARD Puberty BlockersIf a child is looked after under a care order, the local authority has parental responsibility, so it would need to be part of the consent process as the corporate parent. I turn…23 Jun 2026HANSARDPathways Clinical TrialI refer hon. Members to the oral statement I made in the House today, 22 June 2026, on the Pathways clinical trial. [HCWS135]22 Jun 2026HANSARDPathways Study: Puberty SuppressionThis trial has been paused since earlier this year while the MHRA worked to strengthen the safeguards. Those stronger safeguards are now in place, which gives greater protection…22 Jun 2026